Cree Reports Financial Results for the Third Quarter of Fiscal Year 2021

CEW CREE Wolfspeed 400

May 5, 2021

Cree, Inc. announced revenue from continuing operations of $137.3 million for its third quarter of fiscal 2021, ended March 28, 2021. This represents a 21% increase compared to revenue from continuing operations of $113.9 million reported for the third quarter of fiscal 2020, and an 8% increase compared to the second quarter of fiscal 2021. GAAP net loss from continuing operations for the third quarter of fiscal 2021 was $66.5 million, or $0.59 per diluted share, compared to GAAP net loss from continuing operations of $56.2 million, or $0.52 per diluted share, for the third quarter of fiscal 2020. On a nonGAAP basis, net loss from continuing operations for the third quarter of fiscal 2021 was $24.7 million, or $0.22 per diluted share, compared to non-GAAP net loss from continuing operations for the third quarter of fiscal 2020 of $18.4 million, or $0.17 per diluted share.

On March 1, 2021, Cree completed the previously announced sale of certain assets and subsidiaries comprising its former LED Products segment to SMART Global Holdings, Inc. (SGH) and its wholly owned acquisition subsidiary CreeLED, Inc. (CreeLED and collectively with SGH, SMART) for up to $300 million, including fixed upfront and deferred payments and contingent consideration.

“We are building solid momentum and during our fiscal third quarter we continued to execute and drive our strategy, delivering strong top line performance as customers continue to realize the benefits of silicon carbide,” said Cree CEO, Gregg Lowe. “With the sale of our LED business now complete, we accomplished a critical milestone in our journey to becoming a pure-play semiconductor powerhouse and have an even greater focus on converting opportunities in our pipeline and expanding our manufacturing capacity.”

Business Outlook: For its fourth quarter of fiscal 2021, Cree targets revenue in a range of $142 million to $148 million. GAAP net loss is targeted at $68 million to $73 million, or $0.59 to $0.63 per diluted share. Non-GAAP net loss is targeted to be in a range of $25 million to $30 million, or $0.22 to $0.26 per diluted share. Targeted non-GAAP net loss excludes $43 million of estimated expenses, net of tax, related to stock-based compensation expense, amortization or impairment of acquisition-related intangibles, factory optimization restructuring and start-up costs, net accretion on convertible notes and project, transformation, transaction and transition costs. The GAAP and non-GAAP targets do not include any estimated change in the fair value of Cree’s ENNOSTAR (formerly Lextar) investment, which was liquidated earlier this month.

Quarterly Conference Call: Cree will host a conference call at 5:00 p.m. Eastern time today to review the highlights of the third quarter results and the fiscal fourth quarter 2021 business outlook, including significant factors and assumptions underlying the targets noted above. The conference call will be available to the public through a live audio web broadcast via the Internet. For webcast details, visit Cree’s website at investor.cree.com/events.cfm.

Source

Related Articles


Changing Scene


Design

  • How Do the Most Trusted Lighting Brands Stay at the Top

    How Do the Most Trusted Lighting Brands Stay at the Top

    In a competitive and constantly evolving lighting market, staying top-of-mind isn’t just about creating beautiful products, it’s about creating consistent value. Lighting professionals today are inundated with choices. From smart solutions and sustainable tech to design-forward fixtures, the options are vast. But amidst this sea of options, some brands always seem to rise to the… Read More…

  • A New Language of Light: Fluxwerx Unveils Speak Recessed Luminaire Family, Reimagining Architectural Integration & Performance

    A New Language of Light: Fluxwerx Unveils Speak Recessed Luminaire Family, Reimagining Architectural Integration & Performance

    Fluxwerx announces the launch of Speak—the latest addition to their expanding collection of LED luminaires for commercial, institutional, retail, hospitality and residential environments. Breaking from the paradigm of conventional downlights, Speak is a new meticulously designed luminaire family that elevates the dialogue between light, material, and spatial intent. Engineered as an extension of architectural form rather… Read More…


New Products

  • Wow Lighting and Controls: Acclaim Lighting – Terra Linear Series

    Wow Lighting and Controls: Acclaim Lighting – Terra Linear Series

    Terra Linear is Acclaim Lighting’s brand-new in-ground linear series powered by Acclaim’s XTR technology. XTR tech allows for linear runs of up to 1400’ from a single driver and can automatically adapt to any voltage from 100-277 volts AC. It features a low-profile design that is just under 3” wide, is drive-over and walk-over rated,… Read More…

  • Leviton | Viscor: Certolux MD2-3461 – Medical LED Luminaire

    Leviton | Viscor: Certolux MD2-3461 – Medical LED Luminaire

    The MD2-3461 series by Certolux is an IC-rated specification-grade, LED luminaire which provides a cost-effective patient room lighting solution. Designed as a combination Ambient/Exam light for hospitals, nursing homes and other patient care facilities. Eliminates the need for wall mounted luminaires. The flexibility of the nominal 2’ x 4’ singular modular installation makes this an… Read More…